Valion Bio, Inc. Common Stock (NASDAQ:VBIO) Stock Dropped to “Sell” by Wall Street Zen

Wall Street Zen cut shares of Valion Bio, Inc. Common Stock (NASDAQ:VBIO – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Valion Bio, Inc. Common Stock in a report on Thursday, October 15th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Read Our Latest Report on Valion Bio, Inc. Common Stock

Valion Bio, Inc. Common Stock Price Performance

Shares of NASDAQ VBIO traded up $0.02 during trading on Friday, reaching $0.53. The company had a trading volume of 100,191 shares, compared to its average volume of 1,015,439. Valion Bio, Inc. Common Stock has a 52 week low of $0.47 and a 52 week high of $67.50. The stock has a market cap of $471,077.00, a PE ratio of -0.00 and a beta of 1.91. The company has a debt-to-equity ratio of 1.74, a quick ratio of 0.86 and a current ratio of 1.11. The business’s 50 day moving average price is $1.66 and its 200-day moving average price is $13.69.

Valion Bio, Inc. Common Stock Company Profile

(Get Free Report)

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Further Reading

Receive News & Ratings for Valion Bio Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valion Bio Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.